This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Leader In At-Home Laboratory Testing Praises Federal Panel's Recommendations For Widespread HIV Testing

HOFFMAN ESTATES, Ill., Nov. 21, 2012 /PRNewswire/ -- A federal panel's recommendation this week to broaden HIV testing to include nearly all persons 15 to 64 years of age is an important health care development that could result in a significant decrease in the spread of HIV and AIDS, Home Access Health Corporation, the leading manufacturer of at-home laboratory services, said today.

On Monday, the U.S. Preventive Services Task Force, an independent group operating within the Department of Health and Human Services, issued draft guidelines that call for widespread HIV testing as a means to reduce the incidence of AIDS.

"The Preventive Services Task Force's recommendations are an important step forward to combat the spread of AIDS," said Mary Vogt, President of Home Access Health Corporation.  "Too many Americans are simply unaware they are carrying the HIV virus.  Knowing their HIV status is critical and broader testing is the answer."

According to the Centers for Disease Control, approximately 50,000 new HIV infections will occur in the United States this year.  An estimated 1.2 million Americans are currently living with HIV, but about 20 percent – or 240,000 people – are unaware they have the infection.

"Our experience tells us that many at-risk individuals avoid screening due to concerns about the stigma associated with HIV and AIDS.  These individuals want the accuracy of a lab test, while maintaining the confidentiality and anonymity of at-home results.  Increased testing can lead to earlier medical treatment and prevent the transmission of infection," Vogt said. "It's vital for consumers to have the best opportunity for accurate, complete HIV testing and we applaud the Task Force's recommendations."

Home Access Health Corporation manufactures a test that provides an option for anonymous HIV testing.  Approved by the Food and Drug Administration (FDA) in 1996, the Home Access® Express HIV-1 Test System provides users with confirmed results in a single business day.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs